Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Psychopharmacology (Berl). 2011 Jun 4;219(2):411–420. doi: 10.1007/s00213-011-2367-4

Table 1.

Correlation matrix of striatal DAT and post-treatment barrier performance

Post-Tx barriers Post-Tx 25 cm barrier Post-Tx 30 cm barrier NAc DAT CP Subregion DAT

dmCP dlCP vmCP vlCP
Post-Tx barriers 1.00 0.25*** ns ns ns ns
Post-Tx 25 cm barrier 1.00  0.61*** ns ns ns ns ns
Post-Tx 25 cm barrier  1.00 0.36* ns ns ns ns

Scores are reported as r values showing levels of DAT binding in regions of the CP and NAc and their association with post-treatment performance over barriers

Post-Tx barriers post-treatment performance over all barrier heights, post-Tx 25 cm barrier post-treatment performance over the 25-cm barrier, post-Tx 30 cm barrier post-treatment performance over the 30-cm barrier, DAT dopamine transporter, CP caudate putamen, dmCP dorsomedial caudate putamen, dlCP dorsolateral caudate putamen, vmCP ventromedial caudate putamen, vlCP ventrolateral caudate putamen

*

p<0.05;

**

p<0.01;

***

p<0.001